This message contains images. If you don't see images, click here to view.
Advertise in this news brief.




Text Version   RSS   Subscribe   Unsubscribe   Archive   Media Kit          June 11, 2015

Home  |   About SCAI  |   Membership  |   Education  |   Quality  |   Advocacy  |   Careers & Fellows  |   Press  |   Contact Us

 



In this issue...




SCAI NEWS

Where in the World Is SCAI? Society Enjoys Busy Spring in Saudi Arabia, China, India, Turkey, More
SCAI
Where in the world has SCAI been lately? Society leaders have been all over the globe this spring, bringing SCAI's unbiased, evidence- and case-based educational brand to audiences ranging from seasoned interventional cardiologists to interventionalists-in-training.

The Society's spring slate began at CIT 2015 in Beijing, China in March with a SCAI Session on high-risk PCI. Nelson Bernando, MD, FSCAI, Ramesh Daggubati, MD, FSCAI, Peter Duffy, MD, MMM, FSCAI, Spencer King, MD, FSCAI, Ajay Kirtane, MD, FSCAI, and Thach Nguyen, MD, FSCAI explored the latest tools and therapies to serve high-risk patients as well as issues related to quality. A special CIT 2015 issue of SCAI's official journal, Catheterization & Cardiovascular Interventions, was also distributed to attendees.

April was a particularly busy month with Michael Cowley, MD, MSCAI, Ramesh Daggubati, MD, FSCAI, Sundeep Mishra, MD, FSCAI and Bonnie Weiner, MD, MBA, MSEC, MSCAI presenting the SCAI Back-to-Basics Course at NIC 2015 Midmeet in New Delhi, India. Later in the month at SACIS Forum 2015 in Dammam, Saudi Arabia, Ehtisham Mahmud, MD, FSCAI and Robert Applegate, MD, FSCAI chaired a special SCAI session on Bifurcation and Left Main. Capping off April, Tarek Helmy, MD, FSCAI, Ayman Magd, MD, FSCAI, and Ramon Quesada, MD, FSCAI presented the SCAI Advanced Fellows Course in Dubai, UAE.

Just days after SCAI 2015, Mehmet Celingiro, MD, FSCAI, Ty Collins, MD, FSCAI, and Ramesh Daggubati, MD, FSCAI served as faculty on a joint Fellows Course with the Turkish Society of Cardiology in Gural Sapanca, Turkey, reaching approximately 60 interventional cardiology FITs.

What's next for SCAI? Mauricio Cohen, MD, FSCAI, Ted Feldman, MD, MSCAI, and Mayra Guerrero, MD, FSCAI will be presenting during the SCAI TAVR Session at SOLACI/SOCIME 2015 in Mexico City, Mexico on August 7. The Society will also be presenting fellows courses in Chandigarh, India on August 1-2 and Kaifeng China on August 22-23. The Indian course will feature Ramesh Daggubati, MD, FSCAI, Luis Guzman, MD, FSCAI, Sundeep Mishra, MD, FSCAI and Simon Redwood, MD, FSCAI, and the course in China will feature Ehtisham Mahmud, MD, FSCAI and Thomas Tu, MD, FSCAI.
   Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article


PRODUCT SHOWCASE
  Global Interventional Medical Devices
Whether you are a healthcare professional, a patient or simply someone looking to know more about the complete solutions offered by Cordis, let us show you how our distinctive approach to working in partnership with you results in innovative interventional products and services to help support sustained patient outcomes.
 


Last Chance to Weigh In... What Transcatheter Aortic Valve Do You Use?
SCAI
Participate in the TAVR Center's Spring Poll before it closes. We want to know, "Which transcatheter aortic valve do you use?"

So far half of you have told us you use Edwards Sapien XT and Medtronic CoreValves equally, followed by a quarter of you who use the Medtronic CoreValve and 19 percent who use Edwards Sapien XT and 6% who use neither. Participate in the poll now before it closes.

Acknowledgments

The SCAI TAVR Center is supported through an educational grant from platinum sponsor Medtronic. The Society gratefully acknowledges this support while taking sole responsibility for all content developed and disseminated through this effort.

Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


State-of-the-Art PVD Interventions Meet YOUR Real-World Practice
SCAI
Advances in peripheral interventions are moving at a rapid pace and the number of complex PVD patients is rapidly growing. However, present guidelines and data do not adequately inform thoughtful clinicians how to provide the best care for their patients.

The solution? SCAI has developed the Complex Peripheral Interventions Workshop (SCAI CPVI) to help you incorporate state-of-the-art peripheral interventions into your "real-world" practice using a novel, interactive education approach focused on how YOU learn best. CPVI will feature a case-based, intensive focus on Aorto-lliac Intervention, SFA Intervention, and Critical Limb Ischemia. Throw in simulator training on new techniques, case reviews starting weeks before the Workshop, and a flipped classroom, this program will be interactive, social and unlike any other you've attended. Learn more and register now.

Acknowledgments

SCAI gratefully acknowledges the following companies for their generous support of the SCAI Complex Peripheral Interventions course through educational grants while taking sole responsibility for all content developed and disseminated through this event.
  • Silver Sponsor: Terumo Interventional Systems
  • Bronze Sponsors: Abbott; AstraZeneca

  • Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
    READ MORE


    PRODUCT SHOWCASE
      Coming July 2015 . . .
    GLIDESHEATH SLENDER® 5Fr and 7Fr! The only family of unique thin-wall sheaths, offering radial access to more patients.

    • Increase Your Radial Access Options • Optimize Procedural Outcomes • Preserve Arterial Function

    *GLIDESHEATH SLENDER® is currently available in 6Fr.

    ©2015 Terumo Medical Corporation. All rights reserved. All brand names are trademarks or registered trademarks of Terumo. TIS-694-06012015
     


    Have You Seen SCAI's Latest Unbroken Hearts Story? 3 Million Viewers Already Have
    SCAI
    Ian McDonagh was born in a cardiac cath lab. After a quick kiss from his mom, he was whisked to the cath lab next door, where a team of 36 medical professionals were assembled. Led by Alexander Javois, MD, FSCAI, the team performed an atrial septostomy before Ian was an hour old. The procedure marked the start of the heart journey that Ian and his family began over 11 years ago. Last week Ian graduated from elementary school. Join the nearly 3 million people who have seen his story via SecondsCount.org and The Northwest Herald.

    Acknowledgments

    Unbroken Hearts is supported by grants from Abbott and Abiomed. SCAI gratefully acknowledges this support while taking sole responsibility for all content developed and disseminated through the campaign.

    Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
    READ MORE


    'What Medical Device Companies Can Learn from Starbucks' — New Blog by SCAI-ELM Fellow
    SCAI
    It's time to catch up with Starbucks, writes SCAI-ELM Fellow Jordan Safirstein, MD, FSCAI. He's making the case for user-friendly apps that would help patients learn about their cardiovascular condition as well as any devices they’ve had implanted: stents, valves, pacemakers, etc. The same apps could help patients build support networks, remind them to take their medications and schedule their follow-up appointments. Apps like these could have far-reaching impact for individual patients, their families and care teams and even the healthcare system. Read and comment on Dr. Safirstein's blog.
    Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
    READ MORE




    AMA Affirms SCAI's Resolution on the Misuse of Appropriate Use Criteria
    SCAI
    At the American Medical Association (AMA) House of Delegates meeting last week, the AMA affirmed a resolution submitted by SCAI calling for the AMA to oppose the misuse of appropriate use criteria (AUC) by payers. SCAI's resolution came about following policies developed by New York State's Department of Health/Medicaid Program to recoup payments for percutaneous coronary interventions deemed inappropriate according to the 2012 AUC for coronary revascularization. While SCAI has persuaded New York State officials to make significant procedural concessions to this policy, the state's Medicaid program continues to implement this plan and threaten patients' access to medically necessary care. By affirming SCAI's resolution, the AMA acknowledged that such misuse of AUC violates its policy and committed to working with SCAI in fighting similar efforts.
    Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
    READ MORE


    Cardiology Draws Attention to Rising Generic Drug Prices
    SCAI
    A resolution passed at last week's American Medical Association (AMA) House of Delegates meeting is drawing attention to increases in the price of some generic drugs. Submitted by the Heart Rhythm Society and cosponsored by SCAI and other organizations, the resolution has generated media coverage noting that drug manufacturers are using market consolidation efforts to reduce or control the supply of some generic drugs and dramatically increase prices. The AMA has announced that it will "work with Congress and other interested parties to enact legislation to insure fair and appropriate pricing, balancing access and education with competition, of critical generic medications."
    Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article


    INDUSTRY NEWS


    Bivalirudin Plus GPI Cuts Bleeding, Mortality in Heart Failure Patients Undergoing PCI
    TCTMD
    Among patients with congestive heart failure (CHF) who are undergoing PCI, bivalirudin results in less bleeding and lower mortality compared with heparin when each is paired with a glycoprotein IIb/IIIa inhibitor, according to propensity-matched analysis of data from a large registry published online ahead of print in Catheterization and Cardiovascular Interventions. Bivalirudin is also associated with reduced overall hospital costs.
    Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
    READ MORE


    Federal Panel Backs Approval of PCSK9 Inhibitors to Fight Heart Attacks
    The New York Times
    An expert group recommended that the Food and Drug Administration approve PCSK9 inhibitors, a powerful new drug to protect against cardiovascular disease. If approved, it would be the first in a major new class of medicines in a generation that significantly lower levels of cholesterol, the leading risk factor for heart disease. Dr. Joshua W. Knowles, a Stanford cardiologist, called the medicines "a triumph of the modern genetic revolution."

    Related: FDA Approves Amgen for Cholesterol (The Associated Press via U.S. News & World Report)

    Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
    READ MORE


    Advantage of Radial PCI Most Apparent at Extremes of BMI
    TCTMD
    Although the radial approach to PCI is associated with less major bleeding and need for transfusion than femoral access regardless of patients' body mass index (BMI), it is particularly beneficial in those at the low or very high end of the spectrum. The findings, from a large statewide registry, were published online in Catheterization and Cardiovascular Interventions.
    Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
    READ MORE


    Aneurysms Commonly Recur After EVT
    MedPage Today
    The rupture rate more than a decade after endovascular treatment of intracranial aneurysms was very low, but recurrences were relatively common in people whose aneurysms were completely occluded on imaging 3 to 5 years after treatment, researchers reported. In one of the longest, prospective follow-up studies of intracranial aneurysm patients receiving endovascular treatment, the latter was found to be effective for preventing long-term bleeding.
    Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
    READ MORE


    Cognitive Impairment After Stroke Equivalent to 8 Years of Aging
    Neurology Advisor
    Having a stroke can produce a drop in brain function equivalent to nearly eight years of aging, according to data published in Stroke. The study, headed by a team from the University of Michigan, sought to determine causes of racial differences in cognitive decline, but found that both black and white adults were impacted the same after incident stroke.
    Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
    READ MORE


    Combination of a Cholesterol-Lowering Statin and Ezetimibe Lowers Risk of a Heart Attack or Stroke
    Harvard Health
    High cholesterol is a key culprit in the development of cardiovascular disease, the leading cause of death in the United States and many other developed countries. We know that lowering cholesterol helps prevent heart attacks and strokes. But an unanswered question remains: how low should you go? New research published online in The New England Journal of Medicine suggests that lower is better.
    Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
    READ MORE


    Popular Heartburn Meds Linked to Higher Risk of Heart Attack
    HealthDay News
    People who use certain heartburn drugs for a long period of time may have a slightly heightened risk of suffering a heart attack, a new study suggests. Using medical records from nearly 300,000 U.S. adults with acid reflux disease, researchers found that the risk of heart attack was slightly elevated among those using proton pump inhibitors.
    Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
    READ MORE


    Untreated Sleep Apnea Boosts Risk of Heart Disease, Stroke
    MedPage Today
    Obstructive sleep apnea (OSA) may increase the risks of death, heart disease, stroke, and kidney disease, as well as hasten kidney function decline, according to a study of more than 3 million U.S. veterans. Compared with OSA-negative patients, untreated OSA was associated with an 86 percent higher mortality risk and treated OSA was associated with a 35 percent higher mortality risk, wrote Miklos Z. Molnar, MD, PhD, of the University of Tennessee Health Science Center in Memphis, and colleagues, in the journal Thorax.
    Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
    READ MORE


    New Procedure to Obtain Induced Pluripotent Stem Cells
    Phys.Org
    For their ability to differentiate into other cell types, the embryonic stem cells hold a large potential in the medical industry. Their use, however, poses ethical questions due to the fact that in order to obtain them, it is necessary to destroy the embryo. For this reason, medical researches use induced pluripotent stem cells. In fact, it is possible to reprogram adult cells that can be obtained by simply drawing blood and making them "regress" to a similar state to that of embryonic stem cells. The reprogrammed cells are capable of creating all the cell types of an adult organism, such as brain or heart cells.
    Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
    READ MORE


    ONLINE JOB BOARD

    Job Title Employer Location
    Cardiology - Interventional Baptist Health Medical Group Elizabethtown, KY
    Interventional Cardiologist Private Practice Houston, TX
    Monitor Technician, ICU, PRN CHSPSC LLC Huntsville, AL

    For a complete list of job postings, click here
    To post your resume, click here


    CALENDAR OF EVENTS

    Date Event Location
    June 11 SCAI-QIT Webinar: Documentation of PCI Procedures Online
    Aug. 1-2 SCAI Fellows Course at LWSIC Chandigarh, INDIA
    Aug. 5-7 SCAI TAVR Session @ SOLACI Mexico City, MEXICO
    Aug. 22-23 SCAI China Fellows Course Kaifeng, CHINA
    Sept. 25-26 SCAI CPVI - Complex Peripheral Vascular Interventions Washington, D.C.
    Oct. 29-31 SCAI at Great Wall International Congress of Cardiology Beijing, CHINA
    Nov. 13-15 SCAI Fellows Course at AICT 2015 Dhaka, BANGLADESH
    Dec. 6-9 SCAI 2015 Fall Fellows Courses Las Vegas
    Feb. 25 SCAI Session at CardioEgypt 2016 Cairo, EGYPT
    May 4-7, 2016 SCAI 2016 Scientific Sessions Orlando, FL

    CLICK HERE for a Full Calendar of SCAI Events


    The news summaries appearing in SCAI This Week are based on original information from news organizations and are produced by Multibriefs, an independent e-mail newsletter publisher. SCAI is not responsible for the content of sites external to SCAI, nor do reports in SCAI This Week constitute the official opinion of SCAI. The SCAI This Week news roundup is provided as a timely update for SCAI members and other healthcare professionals. Links to articles are provided for readers' convenience and may be of use in discussions with patients or colleagues. Questions and comments about SCAI This Week may be directed to Multibriefs at scai@multibriefs.com.


    TRENDING ARTICLES
    Missed last week's issue? See which articles your colleagues read most.

        New Data Highlight Use of Ticagrelor for Ad-hoc PCI (Healio)
    Image of the Week: What Happened to the Valve? (SCAI)
    Can 'Moderate' Drinking Damage Aging Hearts? (MedPage Today)
    Study Supports Use of Low-Dose Aspirin After Acute MI (TCTMD)
    Will Warfarin Remain the Cornerstone Anticoagulant? (Pharmacy Times)
    Radiation Risks in Procedures Prompt Calls for Solutions (SCAI)

    Don't be left behind. Click here to see what else you missed.


     



    7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063